'Ideas to Innovation' is a podcast from Clarivate, a global leader in providing solutions to accelerate the lifecycle of innovation, helping customers solve some of the world's most complex problems. In Ideas to Innovation Season 2, you will hear inspiring stories told from a personal, on-the-ground perspective from the people who are most passionate about the positive outcomes they helped deliver. These are stories about innovation that, by the end of each episode, you can't help but think: "Wow, they really did that?" Clarivate. Accelerating innovation. https://clarivate.com/
In this concluding episode of Season 3 of "Ideas to Innovation," we reflect on our journey through the episodes published in 2024 that highlight the conversations we’ve enjoyed with some of the brightest minds in education, healthcare and intellectual property law.
In episode 6 in February, we explored America's literacy challenge with documentary filmmaker Jenny Mackenzie. Jenny shared her personal connection to literacy and discussed the innovative strategies being used to promote reading rights across the United States. Her insights into reading proficiency and educational reform were both eye-opening and inspiring.
March brought us a conversation with Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, in episode 7, who detailed the groundbreaking journey of Tarpeyo, a drug that promises to revolutionize the treatment of kidney disease. Renée explained the innovative path to FDA approval, setting new benchmarks in the pharmaceutical industry.
We delved into the impact of artificial intelligence on intellectual property law in episode 8 in April, with Jay Myers from Seyfarth Shaw and Arun Hill from Clarivate. They provided valuable insights into how AI is transforming trademark searches, infringement monitoring and strategic brand decisions while addressing the ethical challenges that come with these advancements.
As we wrap up Season 3, we hope the episodes have informed, inspired, and entertained you. You can also listen to the Season 3 episodes from 2023 – our end-of-year episode summarizes the five stories we shared between September and December.
"Ideas to Innovation" will return later this year with more stories that showcase the power of human intellect and innovation.
Stay curious, and thank you for listening.
16 Apr 2024
Navigating the AI Frontier in Intellectual Property Law
In this episode of Ideas to Innovation, we delve into the transformative influence of artificial intelligence (AI) on intellectual property (IP) and trademark law. Our conversation with guests Jay Myers (https://www.linkedin.com/in/jay-myers-6a36b26/), Director of Innovation for the Intellectual Property Practice Group at the Seyfarth Shaw international law firm, and Arun Hill, Senior Consultant, The Clarivate Center for IP and Innovation Research, unravels the complexities of integrating AI into legal practices.
Our discussion illuminates AI's capacity to streamline trademark searches, enhance infringement monitoring, and inform strategic brand decisions. Yet, it also confronts the ethical dilemmas and practical challenges that accompany AI's rise in the legal domain.
As we peer into the near future, our guests speculate on an era marked by increased efficiency and higher-quality decision-making in IP law, driven by AI's augmentation of human expertise. This vision underscores the importance of balancing technological advancements with the indispensable elements of human judgment and ethical considerations.
This episode offers invaluable insights into how organizations can leverage AI to navigate the complexities of IP law, striking a balance between innovation and the critical human element of legal expertise.
Join us to explore how AI is not only automating tasks but also augmenting the capabilities of IP professionals to achieve higher-quality outcomes for their clients.
7 Mar 2024
Pioneering Paths: The Tarpeyo Journey to FDA Approval and Beyond
The remarkable journey of Calliditas Therapeutics and its groundbreaking drug, Tarpeyo, sheds light on the company’s innovative strategies and relentless pursuit of excellence that led to the successful approval of Tarpeyo by the U.S. Food and Drug Administration (FDA) for the treatment of a specific kidney disease. Our guest in this episode, Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, reveals how their pioneering approach to drug development has set a new benchmark in the pharmaceutical industry.
We explore how Calliditas Therapeutics' groundbreaking work in securing FDA approval not only marks a significant milestone for the company but also inspires a new wave of innovation in the treatment of kidney diseases. Discover the power of pioneering drug development and the bright future it heralds for patients worldwide.
This episode also features insights from Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership at Clarivate, highlighting the importance of the Drugs to Watch 2024 report (https://clarivate.com/drugs-to-watch/) and the potential of Tarpeyo – one of 13 drugs to watch included in the report – to significantly improve patient outcomes.
Discover a story of resilience, innovation, and success behind Tarpeyo's journey to the American market, and the broader implications for the pharmaceutical industry's approach to drug development and regulatory approval.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
4 ratings
Spotify
4.5 / 5
2 ratings
Contact Ideas to Innovation
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Ideas to Innovation?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
